Benedict Robert Lucchesi
#100,162
Most Influential Person Now
Benedict Robert Lucchesi's AcademicInfluence.com Rankings
Benedict Robert Lucchesimedical Degrees
Medical
#1144
World Rank
#1454
Historical Rank
Cardiology
#73
World Rank
#74
Historical Rank
Pharmacology
#81
World Rank
#106
Historical Rank
Benedict Robert Lucchesiphilosophy Degrees
Philosophy
#3885
World Rank
#6198
Historical Rank
Logic
#1480
World Rank
#2244
Historical Rank
Download Badge
Medical Philosophy
Benedict Robert Lucchesi's Degrees
- Masters Medicine University of California, San Francisco
- PhD Pharmacology University of California, San Francisco
Why Is Benedict Robert Lucchesi Influential?
(Suggest an Edit or Addition)Benedict Robert Lucchesi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Reduction of the Extent of Ischemic Myocardial Injury by Neutrophil Depletion in the Dog (1983) (1237)
- Canine Myocardial Reperfusion Injury: Its Reduction by the Combined Administration of Superoxide Dismutase and Catalase (1984) (960)
- Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. (1988) (675)
- Myocardial protection with preconditioning. (1990) (484)
- Mechanisms of myocardial reperfusion injury. (1999) (359)
- Leukocytes and ischemia-induced myocardial injury. (1986) (336)
- Free radicals and myocardial ischemia and reperfusion injury. (1987) (324)
- Free radicals and myocardial injury: pharmacologic implications. (1986) (280)
- Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. (1986) (255)
- The independent effects of oxygen radical scavengers on canine infarct size. Reduction by superoxide dismutase but not catalase. (1985) (238)
- The role of the neutrophil and free radicals in ischemic myocardial injury. (1989) (234)
- Modulation of leukocyte-mediated myocardial reperfusion injury. (1990) (226)
- The Effect of Ibuprofen on Accumulation of Indium‐111‐labeled Platelets and Leukocytes in Experimental Myocardial Infarction (1982) (223)
- Free radicals and tissue injury (1998) (223)
- Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart. (1986) (213)
- Iloprost Inhibits Neutrophil Function In Vitro and In Vivo and Limits Experimental Infarct Size in Canine Heart (1987) (208)
- Cardiac Actions of Glucagon (1968) (190)
- Free radicals and ischemic tissue injury. (1990) (184)
- Effects of Selective Cyclooxygenase-2 Inhibition on Vascular Responses and Thrombosis in Canine Coronary Arteries (2001) (171)
- Electrical induction of coronary artery thrombosis in the ambulatory canine: a model for in vivo evaluation of anti-thrombotic agents. (1980) (170)
- Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation. (1987) (166)
- Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1 (2009) (162)
- Sustained limitation of myocardial reperfusion injury by a monoclonal antibody that alters leukocyte function. (1990) (162)
- Profibrillatory Actions of Pinacidil in a Conscious Canine Model of Sudden Coronary Death (1990) (154)
- The role of nicotine as a determinant of cigarette smoking frequency in man with observations of certain cardiovascular effects associated with the tobacco alkaloid (1967) (148)
- Activation of estrogen receptor-alpha protects the in vivo rabbit heart from ischemia-reperfusion injury. (2005) (146)
- Changes in myocardial threshold. Physiologic and pharmacologic factors in patients with implanted pacemakers. (1967) (145)
- Superoxide Dismutase Conjugated to Polyethylene Glycol Provides Sustained Protection Against Myocardial Ischemia/ Reperfusion Injury in Canine Heart (1988) (134)
- Myocardial ischemia, reperfusion and free radical injury. (1990) (133)
- The complement system in myocardial ischaemia/reperfusion injury. (1994) (132)
- Protective effects of N-2-mercaptopropionyl glycine against myocardial reperfusion injury after neutrophil depletion in the dog: evidence for the role of intracellular-derived free radicals. (1986) (130)
- THE EFFECTS OF PRONETHALOL AND ITS DEXTRO ISOMER UPON EXPERIMENTAL CARDIAC ARRHYTHMIAS. (1965) (125)
- Identification of a Time Window for Therapy to Reduce Experimental Canine Myocardial Injury: Suppression of Neutrophil Activation During 72 Hours of Reperfusion (1988) (125)
- Deficiency of leukocyte surface glycoproteins Mo1, LFA-1, and Leu M5 in a dog with recurrent bacterial infections: an animal model. (1987) (114)
- Effects of complement activation in the isolated heart. Role of the terminal complement components. (1992) (106)
- Myocardial Infarct Quantification in the Dog by Single Photon Emission Computed Tomography (1978) (103)
- Canine Myocardial Reperfusion Injury: Protection by a Free Radical Scavenger, N‐2‐Mcrcaptopropionyl Glycine (1986) (102)
- Effect of BW755C in an occlusion-reperfusion model of ischemic myocardial injury. (1983) (101)
- Ventricular fibrillation resulting from ischemia at a site remote from previous myocardial infarction. A conscious canine model of sudden coronary death. (1982) (100)
- Complement gene expression by rabbit heart: upregulation by ischemia and reperfusion. (1998) (99)
- The positive inotropic action of insulin in the canine heart. (1972) (98)
- Antiplatelet antibody [7E3 F(ab')2] prevents rethrombosis after recombinant tissue-type plasminogen activator-induced coronary artery thrombolysis in a canine model. (1990) (97)
- Free radical scavengers in myocardial ischemia. (1987) (96)
- Reperfusion injury after myocardial infarction: the role of free radicals and the inflammatory response. (1993) (96)
- Complement activation and inhibition in myocardial ischemia and reperfusion injury. (1994) (94)
- Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. (1994) (92)
- O2 free radical-mediated myocardial and vascular dysfunction. (1986) (92)
- ANTIARRHYTHMIC EFFECTS OF BETA ADRENERGIC BLOCKING AGENTS * (1967) (90)
- Effects of Diltiazem on Extent of Ultimate Myocardial Injury Resulting from Temporary Coronary Artery Occlusion in Dogs (1982) (90)
- Free radicals in ischemic myocardial injury. (1985) (86)
- Kinetics of antifibrillatory effects of bretylium: correlation with myocardial drug concentrations. (1980) (86)
- C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion (2002) (85)
- Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion. (1988) (85)
- Effect of superoxide dismutase on myocardial infarct size in the canine heart after 6 hours of regional ischemia and reperfusion: a demonstration of myocardial salvage. (1989) (85)
- Combined adenosine and lidocaine administration limits myocardial reperfusion injury. (1990) (85)
- Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. (1983) (83)
- Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart. (1994) (83)
- Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injury. (1995) (83)
- Electrophysiologic and Antiarrhythmic Effects of Phentolamine in Experimental Coronary Artery Occlusion and Reperfusion in the Dog (1980) (82)
- 17β-Estradiol as a Receptor-Mediated Cardioprotective Agent (2003) (80)
- Sustained Limitation by Superoxide Dismutase of Canine Myocardial Injury Due to Regional Ischemia Followed by Reperfusion (1988) (78)
- Apoptosis in myocardial infarction (2002) (76)
- Prevention of ventricular fibrillation by dextrorotatory sotalol in a conscious canine model of sudden coronary death. (1985) (76)
- Estrogen-Mediated Protection in Myocardial Ischemia-Reperfusion Injury (2008) (74)
- Reduction of experimental canine myocardial infarct size with prostaglandin E1: inhibition of neutrophil migration and activation. (1988) (73)
- The influence of dichloroiso-proterenol (DCI) and related compounds upon ouabain and acetylstrophanthidin induced cardiac arrhythmias. (1961) (73)
- Heparin neutralization by platelet-rich thrombi. Role of platelet factor 4. (1994) (73)
- Antiarrhythmic and antifibrillatory actions of the levo- and dextrorotatory isomers of sotalol. (1984) (72)
- Electrolysis-induced myocardial dysfunction. A novel method for the study of free radical mediated tissue injury. (1986) (70)
- Disodium Disuccinate Astaxanthin (Cardax) Attenuates Complement Activation and Reduces Myocardial Injury following Ischemia/Reperfusion (2005) (69)
- Prostaglandins and prostaglandin inhibitors in ischemic heart disease. (1983) (69)
- Myocardial threshold in patients with artificial pacemakers. (1966) (68)
- Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia. (1992) (68)
- Sulodexide: a renewed interest in this glycosaminoglycan. (2006) (66)
- Scintigraphic detection of regional disruption of adrenergic neurons in the heart. (1988) (66)
- THE ACTION OF NETHALIDE UPON EXPERIMENTALLY INDUCED CARDIAC ARRHYTHMIAS. (1964) (66)
- Purification and characterization of platelet aggregation inhibitors from snake venoms. (1994) (65)
- Augmentation of Streptokinase‐Induced Thrombolysis by Heparin and Prostacyclin (1985) (64)
- Attenuation of interleukin-8 expression in C6-deficient rabbits after myocardial ischemia/reperfusion. (1998) (63)
- The anaphylatoxins C3a and C5a are vasodilators in the canine coronary vasculaturein vitro andin vivo (1991) (62)
- Propranolol (Inderal) in experimentally-induced cardiac arrhythmias. (1966) (61)
- Soluble complement receptor type 1 prevents human complement-mediated damage of the rabbit isolated heart. (1993) (60)
- Thrombogenesis with continuous blood flow in the inferior vena cava (2010) (59)
- Heat Shock Proteins and the Ischemic Heart An Endogenous Protective Mechanism (1993) (59)
- Postinfarction sudden death: significance of inducible ventricular tachycardia and infarct size in a conscious canine model. (1985) (58)
- Protective effects of diltiazem during myocardial ischemia in isolated cat hearts. (1981) (58)
- Antiplatelet monoclonal F(ab')2 antibody directed against the platelet GPIIb/IIIa receptor complex prevents coronary artery thrombosis in the canine heart. (1989) (57)
- Cardioprotective Effects of Ibuprofen in Experimental Regional and Global Myocardial Ischemia (1982) (57)
- Protective effects of the SOD-mimetic SC-52608 against ischemia/reperfusion damage in the rabbit isolated heart. (1994) (57)
- Effects of Beta‐Receptor Blockade and Glucagon on the Atrioventricular Transmission System in the Dog (1968) (56)
- Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761). (1976) (56)
- Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden death. (1987) (56)
- The pharmacology of beta-adrenergic blocking agents. (1969) (55)
- Protection Against Programmed Electrical Stimulation-Induced Ventricular Tachycardia and Sudden Cardiac Death by NE-10064, a Class III Antiarrhythmic Drug (1993) (54)
- Microvascular permeabilization and cardiomyocyte injury provoked by myocardial contrast echocardiography in a canine model. (2006) (53)
- Antiarrhythmic and antifibrillatory actions of the beta adrenergic receptor antagonist, dl-sotalol. (1984) (53)
- Inability of Methylprednisolone Sodium Succinate to Decrease Infarct Size or Preserve Enzyme Activity Measured 24 Hours after Coronary Occlusion in the Dog (1977) (53)
- Ischemia depletes dystrophin and inhibits protein synthesis in the canine heart: mechanisms of myocardial ischemic injury. (2005) (53)
- Apolipoprotein A-IMilano and 1-Palmitoyl-2-oleoyl Phosphatidylcholine Complex (ETC-216) Protects the in Vivo Rabbit Heart from Regional Ischemia-Reperfusion Injury (2004) (53)
- Prevention of arterial thrombosis by intravenously administered platelet P2T receptor antagonist AR-C69931MX in a canine model. (2000) (51)
- Actions of Pinacidil at a Reduced Potassium Concentration: A Direct Cardiac Effect Possibly Involving the ATP‐Dependent Potassium Channel (1993) (51)
- Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis. (1994) (49)
- Complement, neutrophils and oxygen radicals in myocardial-ischemia reperfusion injury (1992) (49)
- Effects of Propranolol and Its Stereoisomers upon Coronary Vascular Resistance (1967) (49)
- Platelet‐Activating Factor and the Release of a Platelet‐Derived Coronary Artery Vasodilator Substance in the Canine (1986) (48)
- Free radicals upregulate complement expression in rabbit isolated heart. (2000) (48)
- Complement, neutrophils and free radicals: mediators of reperfusion injury. (1994) (48)
- Complement inhibitors in myocardial ischemia/reperfusion injury. (1997) (47)
- The beneficial effects of oral ibuprofen on coronary artery thrombosis and myocardial ischemia in the conscious dog. (1980) (47)
- Sildenafil Citrate for Prophylaxis of Nephropathy in an Animal Model of Contrast-Induced Acute Kidney Injury (2014) (47)
- Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist. (1996) (47)
- 17Beta-estradiol as a receptor-mediated cardioprotective agent. (2003) (46)
- Sulodexide Attenuates Myocardial Ischemia/Reperfusion Injury and the Deposition of C-Reactive Protein in Areas of Infarction without Affecting Hemostasis (2005) (45)
- The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. (1991) (41)
- Thromboxane synthetase inhibition with CGS 13080 improves coronary blood flow after streptokinase-induced thrombolysis. (1987) (41)
- Risk of Ventricular Proarrhythmia with Selective Opening of the Myocardial Sarcolemmal versus Mitochondrial ATP-Gated Potassium Channel (2004) (41)
- Prevention of Occlusive Coronary Artery Thrombosis by Prostacyclin Infusion in the Dog (1981) (41)
- Myocardial dysfunction and coronary vasoconstriction induced by platelet-activating factor in the post-infarcted rabbit isolated heart. (1988) (40)
- Complement activation, neutrophils, and oxygen radicals in reperfusion injury. (1993) (38)
- Chimeric 7E3 Prevents Carotid Artery Thrombosis in Cynomolgus Monkeys (1994) (38)
- Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. (1983) (38)
- The Preparation and Characterization of Novel Peptide Antagonists to Thrombin and Factor VIIa and Activation of Protease-Activated Receptor 1 (2004) (37)
- High dose intravenous aspirin, not low dose intravenous or oral aspirin, inhibits thrombus formation and stabilizes blood flow in experimental coronary vascular injury. (1993) (37)
- Cardioprotective effects of amlodipine in the ischemic-reperfused heart. (1989) (36)
- Glucagon: Its Enhancement of Atrioventricular Nodal Pacemaker Activity and Failure to Increase Ventricular Automaticity in Dogs (1969) (36)
- Xanthine Oxidase Inhibition Does Not Limit Canine Infarct Size (1991) (36)
- The Nitroglycerin Polymer Gel Matrix System: A New Method for Administering Nitroglycerin Evaluated with Plasma Nitroglycerin Levels (1982) (36)
- The semisynthetic polysaccharide pentosan polysulfate prevents complement-mediated myocardial injury in the rabbit perfused heart. (1998) (36)
- Electrolytic Inferior Vena Cava Model (EIM) of Venous Thrombosis (2011) (35)
- Protective effects of AICAriboside in the globally ischemic isolated cat heart. (1985) (35)
- Antifibrillatory and Profibrillatory Actions of Selected Class I Antiarrhythmic Agents (1993) (34)
- Inhibition of coronary artery reocclusion after thrombolysis with an RGD‐containing peptide with no significant effect on bleeding time (1993) (34)
- Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. (1983) (34)
- Myocardial ischemia and reperfusion: The role of oxygen radicals in tissue injury (2004) (34)
- Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol. (1987) (33)
- Estrogen Protects the Heart From Ischemia-Reperfusion Injury via COX-2-Derived PGI2 (2008) (33)
- Reduction of myocardial infarct size after ischemia and reperfusion by the glycosaminoglycan pentosan polysulfate. (1999) (33)
- Effect of ranolazine on infarct size in a canine model of regional myocardial ischemia/reperfusion. (1994) (32)
- Phorbol ester-induced ventricular fibrillation in the Langendorff-perfused rabbit heart: antagonism by staurosporine and glibenclamide. (1993) (32)
- Are ECG premature complexes induced by ultrasonic cavitation electrophysiological responses to irreversible cardiomyocyte injury? (2011) (32)
- The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360. (1975) (32)
- Effects of Lodoxamide on Ischemic Reperfused Myocardium (1982) (32)
- Alpha-adrenergic influences in canine ischemic sudden death: effects of alpha 1-adrenoceptor blockade with prazosin. (1987) (32)
- Electrophysiologic Actions of Lidocaine in a Canine Model of Chronic Myocardial Ischemic Damage—Arrhythmogenic Actions of Lidocaine (1982) (32)
- Apolipoprotein A-IMilano/POPC complex attenuates post-ischemic ventricular dysfunction in the isolated rabbit heart. (2008) (31)
- Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. I. Adjunctive Therapy with Monoclonal Antibody 7E3 F(ab')2 Fragment (1994) (31)
- Ischemic-induced alterations in cardiac sensitivity to digitalis. (1979) (31)
- Antiarrhythmic and Electrophysiologic Actions of CK‐357 and Sematilide in a Conscious Canine Model of Sudden Coronary Death (1990) (31)
- Protective Effects of Ranolazine on Ventricular Fibrillation Induced by Activation of the ATP-Dependent Potassium Channel in the Rabbit Heart (1996) (31)
- Beneficial effects of nafazatrom on ischemic reperfused myocardium. (1984) (31)
- Inflammation and myocardial infarction. (1987) (30)
- Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog. (1984) (30)
- Inhibition of in vivo myocardial ischemic and reperfusion injury by a synthetic manganese-based superoxide dismutase mimetic. (1994) (29)
- Platelet GPIIb/IIIa receptor inhibition by SC-49992 prevents thrombosis and rethrombosis in the canine carotid artery. (1993) (29)
- Effects of the Positive Inotropic Agents Milrinone and Pimobendan on the Development of Lethal Ischemic Arrhythmias in Conscious Dogs with Recent Myocardial Infarction (1989) (29)
- Antithrombotic efficacy of a recombinant nematode anticoagulant peptide (rNAP5) in canine models of thrombosis after single subcutaneous administration. (1997) (28)
- The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol. (1973) (28)
- Effects of Dimethyl Propranolol (UM-272; SC-27761) on Myocardial Ischemic Injury in the Canine Heart after Temporary Coronary Artery Occlusion (1978) (28)
- Selective inhibition of the alternative complement pathway by sCR1[desLHR-A] protects the rabbit isolated heart from human complement-mediated damage. (1996) (28)
- The anti-factor D antibody, MAb 166-32, inhibits the alternative pathway of the human complement system. (1999) (27)
- The cardiac beta-adrenergic receptor blocking actions of propranolol and its stereoisomers. (1967) (27)
- Potassium channel openers are likely to be proarrhythmic in the diseased human heart. (1994) (27)
- Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate. (1981) (27)
- Effects of tedisamil (KC‐8857) on cardiac electrophysiology and ventricular fibrillation in the rabbit isolated heart (1996) (26)
- Identification of hydrogen peroxide and hydroxyl radicals as mediators of leukocyte-induced myocardial dysfunction. Limitation of infarct size with neutrophil inhibition and depletion. (1985) (26)
- Preclinical Evaluation of S18886 in an Experimental Model of Coronary Arterial Thrombosis (2006) (26)
- Ex vivo reversal of heparin-mediated cardioprotection by heparinase after ischemia and reperfusion. (1999) (26)
- Sustained inhibition of the vessel wall‐platelet interaction after deep coronary artery injury by temporary inhibition of the platelet glycoprotein llb/llla receptor (1992) (26)
- Potentiation of the antithrombotic effect of prostacyclin by simultaneous administration of aminophylline in a canine model of coronary artery thrombosis. (1983) (26)
- Disodium Disuccinate Astaxanthin Prevents Carotid Artery Rethrombosis and ex vivo Platelet Activation (2008) (26)
- Interaction of the formed elements of blood with the coronary vasculature in vivo. (1987) (25)
- Clinical Pharmacokinetics of Intravenous and Oral Bretylium Tosylate in Survivors of Ventricular Tachycardia or Fibrillation: Clinical Application of a New Assay for Bretylium (1981) (25)
- Cardioprotective effects of amlodipine in the ischemic-reperfused heart. (1989) (25)
- Effects of flecainide acetate on ventricular tachyarrhythmia and fibrillation in dogs with recent myocardial infarction. (1987) (25)
- Sulfhydryl compounds, captopril, and MPG inhibit complement-mediated myocardial injury. (1994) (25)
- Identification of Hydrogen Peroxide and Hydroxyl Radical as Mediators of LeukocyteInduced Myocardial Dysfunction (1985) (24)
- Effects of cyclooxygenase inhibition on canine coronary artery blood flow and thrombosis. (2008) (24)
- Antifibrillatory actions of nadolol. (1982) (24)
- Thrombostatin Inhibits Induced Canine Coronary Thrombosis (1999) (24)
- N-Acetylheparin Pretreatment Reduces Infarct Size in the Rabbit (1999) (24)
- Electrophysiology and Antiarrhythmic Actions of E‐4031 in the Experimental Animal Model of Sudden Coronary Death (1991) (23)
- Oral and intravenous bretylium disposition (1980) (23)
- Orally effective CVS-1123 prevents coronary artery thrombosis in the conscious dog. (1996) (23)
- LU 51198, a highly sulfated, low-molecular-weight heparin derivative, prevents complement-mediated myocardial injury in the perfused rabbit heart. (1997) (23)
- MS‐551 Protects Against Ventricular Fibrillation in a Chronic Canine Model of Sudden Cardiac Death (1995) (23)
- Preconditioning reduces myocardial complement gene expression in vivo. (2000) (23)
- TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog. (1997) (23)
- Tedisamil and dofetilide‐induced torsades de pointes, rate and potassium dependence (2001) (23)
- CVS-1123, a direct thrombin inhibitor, prevents occlusive arterial and venous thrombosis in a canine model of vascular injury. (1997) (22)
- Ibuprofen-mediated infarct size reduction: effects on regional myocardial function in canine myocardial infarction in canine myocardial infarction. (1982) (22)
- Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models. (1985) (22)
- Lanthanum staining of coronary microvascular endothelium: effects of ischemia reperfusion, propranolol, and atenolol. (1981) (22)
- In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood. (1998) (22)
- Nitroglycerin inhibits experimental thrombosis and reocclusion after thrombolysis. (1994) (22)
- Streptokinase thrombolysis in experimental coronary artery thrombosis: pattern of reflow and effect of a stenosis. (1984) (22)
- Hypothyroidism Renders Protection Against Lethal Ventricular Arrhythmias in a Conscious Canine Model of Sudden Death (1991) (22)
- Antithrombotic Effects of DMP 728, a Platelet GPIIb/IIIa Receptor Antagonist, in a Canine Model of Arterial Thrombosis (1994) (22)
- Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury. (1986) (21)
- Antifibrillatory efficacy of long-term tedisamil administration in a postinfarcted canine model of ischemic ventricular fibrillation. (1998) (21)
- Disopyramide-induced ventricular tachycardia. (1980) (21)
- Prevention of Chronic Canine Ventricular Tachyarrhythmias with Bretylium Tosylate (1981) (21)
- Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion. (1987) (21)
- Modulation of myoglobin-H2O2-mediated peroxidation reactions by sulfhydryl compounds. (1988) (21)
- Reduction of myocardial infarct size in vivo by carbohydrate-based glycomimetics. (1998) (20)
- The antiarrhythmic properties of ICI 46037, a quaternary analog of propranolol. (1968) (20)
- The beneficial effects of nafazatrom (BAYg6575) on experimental coronary thrombosis. (1984) (20)
- Effects of diltiazem upon experimental ventricular dysrhythmias. (1983) (20)
- Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs. (1985) (20)
- Medroxyprogesterone acetate prevents the cardioprotective and anti-inflammatory effects of 17beta-estradiol in an in vivo model of myocardial ischemia and reperfusion. (2007) (20)
- Effects of Pimobendan (UD‐CG 115 BS), a New Positive Inotropic Agent, on Ventricular Tachycardia and Ischemic Ventricular Fibrillation in a Conscious Canine Model of Recent Myocardial Infarction (1988) (19)
- Therapeutic potential of complement inhibitors in myocardial ischaemia (2000) (19)
- The Pathway-Selective Estrogen Receptor Ligand WAY-169916 Reduces Infarct Size After Myocardial Ischemia and Reperfusion by an Estrogen Receptor Dependent Mechanism (2007) (19)
- Facilitation of lethal ventricular arrhythmias by therapeutic digoxin in conscious post infarction dogs. (1986) (19)
- The effect of sympatholytic agents on the cardiovascular responses produced by the injection of acetylstrophanthidin into the cerebral ventricles. (1969) (19)
- Protective effects of β-adrenergic blockade in isolated ischemic hearts☆ (1980) (19)
- Combined adenosine and lidocaine administration limits myocardial reperfusion injury (1989) (19)
- Intimatan prevents arterial and venous thrombosis in a canine model of deep vessel wall injury. (2002) (18)
- Antifibrillatory Actions of d, l‐Nadolol in a Conscious Canine Model of Sudden Coronary Death (1983) (18)
- Preconditioning reduces tissue complement gene expression in the rabbit isolated heart. (1999) (18)
- Effect of hypoxia and reoxygenation on the isolated rabbit heart determined by monoclonal antimyosin antibody uptake. (1993) (18)
- Prevention of experimental carotid artery thrombosis by applaggin. (1993) (18)
- Effect of OKY-1581, a thromboxane synthetase inhibitor, on coronary thrombosis in the conscious dog. (1984) (18)
- Antithrombotic effect of GYKI-14766 in a canine model of arterial and venous rethrombosis: a comparison with heparin. (1996) (17)
- Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent. (1988) (17)
- Monoclonal Antibody [7E3 F(ab')2] Prevents Arterial But Not Venous Rethrombosis (1995) (17)
- Thrombostatin Inhibits Cyclic Flow Variations in Stenosed Canine Coronary Arteries (2001) (17)
- The Comparative Antiarrhythmic Actions of Lidocaine and its Quarternary Derivative, Methyl Lidocaine (1974) (17)
- Increased rat cardiac allograft survival by the glycosaminoglycan pentosan polysulfate. (1999) (16)
- Prevention of Rethrombosis After Coronary Thrombolysis in a Chronic Canine Model. II. Adjunctive Therapy with r‐Hirudin (1994) (16)
- Reduction in digitalis-associated postinfarction mortality with nadolol in conscious dogs. (1988) (16)
- Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists (2004) (16)
- Tedisamil in a chronic canine model of atrial flutter. (1999) (16)
- In Vivo Models of Thrombosis (1999) (16)
- Effect of 4-(2-hydroxy-3-isopropylaminopropoxy) acetanilide (AY 21,011) on the myocardial and coronary vascular responses to adrenergic stimulation. (1971) (16)
- Reduction oftheExtent ofIschemic Myocardial Injury byNeutrophil Depletion intheDog (1983) (16)
- Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium. (1980) (16)
- Time-dependent changes in canine cardiac mitochondrial function and ultrastructure resulting from coronary occlusion and reperfusion (1980) (16)
- Oxygen radicals: Systemic events and disease processes (1990) (16)
- The cardiac pharmacology of tolbutamide. (1975) (16)
- Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs. (1997) (16)
- Antiarrhythmic versus antifibrillatory actions: inference from experimental studies. (1993) (16)
- Myocardial Ischemia: The Potential Therapeutic Role of Prostacyclin and Its Analogues (1987) (15)
- Sublytic complement attack reduces infarct size in rabbit isolated hearts: evidence for C5a-mediated cardioprotection. (2000) (15)
- Antiarrhythmic Agent, MS‐551, Protects Against Pinacidil + Hypoxia‐Induced Ventricular Fibrillation in Langendorff‐Perfused Rabbit Isolated Heart (1994) (15)
- Antifibrillatory effects of ibutilide in the rabbit isolated heart: mediation via ATP-dependent potassium channels. (1993) (15)
- Effect of thrombolysis on myocardial injury: recombinant tissue plasminogen activator vs. alfimeprase. (2006) (15)
- Formation, Reactivity, and Antiplatelet Activity of Mixed Disulfide Conjugates of Clopidogrel (2013) (15)
- Electrophysiologic effects of disopyramide phosphate on reentrant ventricular arrhythmia in conscious dogs after myocardial infarction. (1980) (15)
- Experimental Coronary Artery Thrombosis in the Absence of Thromboxane A2 Synthesis: Evidence for Alternate Pathways for Coronary Thrombosis (1985) (15)
- Pharmacological Modification of Arrhythmias After Experimentally Induced Acute Myocardial Infarction: Drugs Acting on the Nervous System (1975) (15)
- Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation. (1989) (15)
- Cardiac electrophysiologic effects of acute and chronic amiodarone administration in the isolated perfused rabbit heart: altered thyroid hormone metabolism. (1986) (15)
- Reduction of Myocardial Infarct Size in the Rabbit by a Carbohydrate Analog of Sialyl Lewisx (1996) (14)
- Protection of Myocardial Function and Coronary Vasculature by Streptokinase (1988) (14)
- Portrayal of adrenergic denervation in the presence of myocardial infarction: a feasibility study. (1990) (14)
- Disopyramide Plasma and Myocardial Tissue Concentrations as They Relate to Antiarrhythmic Activity (1979) (14)
- Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs. (1998) (14)
- The role of adhesion molecules in cardiovascular pharmacology: meeting review. (1995) (14)
- SNC-80-induced Preconditioning: Selective Activation of the Mitochondrial Adenosine Triphosphate-gated Potassium Channel (2003) (14)
- Inhibition of Platelet-Activating Factor Fails to Limit Ischemia and Reperfusion-Induced Myocardial Damage (1992) (14)
- Bretylium: a prototype for future development of antidysrhythmic agents. (1983) (13)
- Sensitive gas chromatographic assay for the quantitation of bretylium in plasma, urine and myocardial tissue. (1980) (13)
- Neutrophils and altered myocardial function. (2000) (13)
- Protection of ischemic myocardium by pharmacologic manipulation of leukocyte function (1992) (13)
- Cardioprotective effects of amlodipine on ischemia and reperfusion in two experimental models. (1990) (13)
- Recombinant Kunitz Protease Inhibitory Domain of the Amyloid β-Protein Precursor as an Anticoagulant in Venovenous Extracorporeal Circulation in Rabbits (1999) (13)
- Role of Calcium on Excitation‐Contraction Coupling in Cardiac and Vascular Smooth Muscle (1989) (12)
- Long-term intravenous infusion of antiarrhythmic drugs using a totally implanted drug delivery system. (1981) (12)
- Electrophysiological effects of prazosin during acute myocardial ischemia (1986) (12)
- Serial Electrophysiologic Effects of Bretylium in Man and Their Correlation with Plasma Concentrations (1982) (12)
- The Antithrombotic Effect of Melagatran in Combination With Clopidogrel and/or Aspirin (carotid artery primary thrombosis study) (2005) (12)
- Oral Pretreatment With Liposomal Glutathione Attenuates Reperfusion Injury in Rabbit Isolated Hearts (2013) (12)
- An isolated, blood-perfused, feline heart preparation for evaluating pharmacological interventions during myocardial ischemia. (1980) (12)
- EFFECT OF QUINIDINE AND PROCAINE AMIDE UPON ACETYLSTROPHANTHIDIN CARDIOTOXICITY. (1964) (12)
- Prevention of experimental carotid and coronary artery thrombosis by the glycoprotein IIb/IIIa receptor antagonist CRL42796 (2002) (12)
- Thromboxane Antagonism in Experimental Canine Carotid Artery Thrombosis (1993) (12)
- Conversion of Atrial Fibrillation by the Experimental Antiarrhythmic Drug Tedisamil in Two Canine Models (2001) (11)
- Tedisamil Attenuates Ventricular Fibrillation in a Conscious Canine Model of Sudden Cardiac Death (1996) (11)
- Methylprednisolone Sodium Succinate Treatment in Global Ischemia of the Cat Isolated Heart (1979) (11)
- Clinical pharmacology of antiarrhythmic therapy (1984) (11)
- Recombinant single-chain urokinase-type plasminogen activator (rscu-PA) induces thrombolysis and systemic fibrinolysis in a canine model of coronary artery thrombosis. (1988) (11)
- Electrophysiologic Effects of Bretylium Tosylate on the Canine Heart During Coronary Artery Occlusion and Reperfusion (1983) (11)
- Antiarrhythmic and electrophysiologic properties of UM-272, dimethyl quaternary propranolol, in the canine heart. (1973) (11)
- Sudden coronary death: pharmacological interventions for the prevention of ventricular fibrillation (1984) (11)
- Alinidine Reduces the Incidence of Ischemic Ventricular Fibrillation in a Conscious Canine Model, a Protective Effect Antagonized by Overdrive Atrial Pacing (1989) (10)
- Antiarrhythmic and antifibrillatory properties of aprindine. (1975) (10)
- Effect of digoxin on the extent of injury and the severity of arrhythmias during acute myocardial ischemia and infarction in the dog. (1988) (10)
- Antifibrillatory actions of bepridil and butyl-MDI, two intracellular calcium antagonists. (1985) (10)
- Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model. (1999) (10)
- Myocardial Reperfusion Injury—Role of Free Radicals and Mediators of Inflammation (2001) (10)
- Conditioned blood reperfusion during angioplasty (CoBRA) treatment of acute myocardial infarction (2001) (10)
- Effect of Zomepirac on Experimental Coronary Artery Thrombosis and Ischemic Myocardial Injury in the Conscious Dog (1983) (10)
- Increase in experimental infarct size with digoxin in a canine model of myocardial ischemia-reperfusion injury. (1988) (10)
- Cardiac Arrhythmia and Injury Induced in Rats by Burst and Pulsed Mode Ultrasound With a Gas Body Contrast Agent (2009) (10)
- Comparative Effects of Prenalterol and Dobutamine in a Canine Model of Acute Ischemic Heart Failure (1981) (10)
- Antifibrillatory effects of clofilium in the rabbit isolated heart (1994) (10)
- Cardiac electrophysiologic actions of SCH 19927 (Dilevalol), the R,R-isomer of labetalol. (1986) (10)
- Comparative effects of aspartate and glutamate during myocardial ischemia. (1981) (10)
- Antiarrhythmic and arrhythmogenic actions of methyl lidocaine during the recovery phase after canine myocardial infarction. (1988) (10)
- Coronary Artery Vasodilation in the Canine: Physiological and Pharmacological Roles of β‐Adrenergic Receptors (1987) (9)
- Antifibrillatory efficacy of concomitant beta adrenergic receptor blockade with dilevalol, the R,R-isomer of labetalol, and muscarinic receptor blockade with methylscopolamine. (1987) (9)
- Myocardial imaging using emission computed tomography. (1978) (9)
- Antidysrhythmic actions of meobentine sulfate. (1984) (9)
- Glycoprotein IIb/IIIa Receptor Antagonist (2S)-2-[(2-Naphthyl-sulfonyl)amino]-3-{[2-({4-(4-piperidinyl)-2-[2-(4-piperidinyl)ethyl] butanoyl}amino)acetyl]amino}propanoic Acid Dihydrochloride (CRL42796), in Combination with Aspirin and/or Enoxaparin, Prevents Coronary Artery Rethrombosis after Success (2003) (9)
- Effects of dimethyl quaternary propranolol (UM-272) on oxygen consumption and ischemic ST segment changes in the canine heart. (1975) (9)
- Thrombostatin FM compounds: direct thrombin inhibitors – mechanism of action in vitro and in vivo (2008) (9)
- The effect of diltiazem on coronary thrombosis in the conscious canine. (1982) (9)
- Effect of Ramiprilat or Captopril on Myocardial Infarct Size: Assessment in Canine Models of Ischemia Alone and Ischemia with Reperfusion (1998) (8)
- Superoxide dismutase does not cause scar thinning after myocardial infarction. (1987) (8)
- Cardioprotective effects of amlodipine in animal models of ischemia and reperfusion. (1991) (8)
- Intimatan (dermatan 4,6-O-disulfate) prevents rethrombosis after successful thrombolysis in the canine model of deep vessel wall injury. (2006) (8)
- Effects of bepridil on regional and global myocardial ischemia/reperfusion-induced injury. (1985) (8)
- Platelet depletion in experimental myocardial infarction (1985) (8)
- Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity. (1989) (8)
- Do catecholamines play a physiologic role in regulating corpus luteum function in the pseudopregnant rabbit? (1985) (8)
- Recombinant hirudin reduces the incidence of thrombotic occlusion in a canine model of coronary vascular injury (1991) (8)
- Acute cocaine exposure up-regulates complement expression in rabbit heart. (2000) (8)
- α-Adrenergic Influences in Canine Ischemic Sudden Death (1987) (8)
- The Mechanism for the Clonidine‐Induced Coronary Artery Dilatation in the Canine Heart (1988) (8)
- 5-hydroxydecanoate fails to attenuate ventricular fibrillation in a conscious canine model of sudden cardiac death. (1996) (8)
- Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation. (1994) (7)
- Electrophysiologic and antiarrhythmic actions of nadolol: acute ischemia in the presence of previous myocardial infarction. (1988) (7)
- Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure. (1973) (7)
- Plasma and myocardial tissue concentrations of UM-272 (N,N-dimethylpropranolol) after oral administration in dogs. (1980) (7)
- Ventricular fibrillation in a conscious canine model--its prevention by UM-272. (1983) (7)
- MYOCARDIAL REPERFUSION INJURY (1990) (7)
- Development of Ventricular Tachyarrhythmias in the Conscious Canine During the Recovery Phase of Experimental Ischemic Injury: Effect of Bethanidine Administration (1984) (7)
- Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium. (1984) (7)
- Electrophysiologic Effects of Bepridil in Normal and Infarcted Canine Myocardium (1986) (7)
- Effects of Combined Thromboxane Synthetase Inhibition/Thromboxane Receptor Antagonism in Two Models of Sudden Cardiac Death in the Canine: Limited Role for Thromboxane (1990) (6)
- Reviparin-sodium prevents complement-mediated myocardial injury in the isolated rabbit heart. (1997) (6)
- α‐Adrenergic Influences in Canine Ischemic Sudden Death: Effects of α1-Adrenoceptor Blockade with Prazosin (1987) (6)
- Potential organ- or tumor-imaging agents XIX: radioiodinated antiarrhythmic drugs as potential myocardial imaging agents. (1980) (6)
- Protection of Reperfused Ischemic Canine Myocardium by CI‐922, a New Inhibitor of Leukocyte Activation (1988) (6)
- The Role of the Polymorphonuclear Leukocyte in Mediating Myocardial Reperfusion Injury (1988) (6)
- Streptokinase improves reperfusion blood flow after coronary artery occlusion. (1989) (6)
- The in vivo thrombolytic activity of K2tu-PA, a hybrid plasminogen activator and fibrinolytic agent (1991) (6)
- Antifibrillatory action of bretylium: role of the sympathetic nervous system. (1987) (6)
- polyethylene glycol結合型superoxide dismutaseの心筋梗塞巣縮小効果 (1989) (6)
- The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424. (1976) (5)
- [Limitation of myocardial infarct size by polyethylene glycol-conjugated superoxide dismutase in a canine model of 90 min coronary occlusion followed by 4 days of reperfusion]. (1989) (5)
- Effect of diltiazem on experimental coronary artery thrombosis in dogs. (1990) (5)
- Dermatan disulfate (Intimatan) prevents complement-mediated myocardial injury in the human-plasma-perfused rabbit heart. (2005) (5)
- Effect of pranolium on ventricular tachycardia induced in canine myocardium after myocardial infarction (1978) (5)
- The positive inotropic effect of glucagon in the chronically failed right ventricle as demonstrated in the isolated cat heart. (1975) (5)
- Electrophysiologic effects of UM-272 on myocardial ischemia in the canine heart. (1978) (5)
- Heat stress protects the perfused rabbit heart from complement-mediated injury. (1996) (5)
- Effect of Sodium/Hydrogen Exchange Inhibition on Myocardial Infarct Size after Coronary Artery Thrombosis and Thrombolysis (2006) (5)
- Antiarrhythmic Actions of Left Stellectomy in Digitalis‐Mediated Malignant Ventricular Arrhythmias in the Postinfarcted Canine Heart (1988) (5)
- Effect of time of 7E3 administration on rt-PA-induced reperfusion: study in a canine model of thrombus-based occlusion-reperfusion. (1999) (5)
- Chronic Ventricular Tachyarrhythmias in the Conscious Dog: Prevention by UM‐272 (Dimethylpropranolol) (1981) (5)
- The effects of calcium entry blockade on the vulnerability of infarcted canine myocardium toward ventricular fibrillation. (1986) (5)
- Heparin Neutralization by Platelet-Rich Thrombi (2005) (4)
- Therapeutic advances in the management of cardiac arrhythmias: III - Verapamil (1982) (4)
- The action of dichloroisoproterenol (DCI) and several other pharmacological agents upon the aconitine-induced ventricular arrhythmia in the isolated rabbit heart. (1962) (4)
- Correlation between the in vivoEff icacy of GPIIb/IIIa Receptor Antagonists (m7E3, MK-383 and DMP-728) and ex vivo Platelet Inhibition (1999) (4)
- Electrophysiologic actions of pirmenol in dogs with recent myocardial infarction. (1986) (4)
- Prevention of Carotid Artery Thrombosis After Oral Administration of the Glycoprotein IIb/IIIa Antagonist CRL42796 (2003) (4)
- Effects of BMY21190, an inhibitor of cAMP phosphodiesterase, on infarct size and myeloperoxidase activity in the ischemic myocardium of a canine occlusion-reperfusion model. (1995) (4)
- Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias. (1973) (4)
- UK-68,798, a class III antiarrhythmic drug with antifibrillatory properties (1992) (4)
- Lethal Myocardial “Reperfusion Injury” (2004) (4)
- Protective effects of dimethyl-propranolol (UM-272) during global ischemia of isolated feline hearts. (1980) (4)
- Functional consequence of big endothelin conversion: demonstration with isolated neutrophils but not in a postinfarction model. (1993) (4)
- The effects of tolbutamide on cardiac contractility and coronary blood flow in the canine heart (1973) (4)
- Mitochondrial function after global cardiac ischemia and reperfusion: Influences of organelle isolation protocols (1981) (4)
- Electrophysiologic effects of prazosin during acute myocardial ischemia. (1986) (3)
- Antifibrillatory actions of HBI‐3000 in the conscious canine model of sudden cardiac death (2009) (3)
- EFFECT OF INFARCT SIZE LIMITATION BY PROPRANOLOL ON VENTRICULAR ARRHYTHMIAS AFTER MYOCARDIAL INFARCTION (1982) (3)
- The autonomic nervous system, myocardial infarct size and ventricular fibrillation. (1993) (3)
- Antithrombotic effects of BMY21190, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis. (1993) (3)
- Changes in cardiac muscle function and biochemistry produced by long-term amiodarone and amiodarone + triiodothyronine administration in the rabbit. (1987) (3)
- Antithrombotic efficacy of single subcutaneous administration of a recombinant nematode anticoagulant peptide (rNAP5) in a canine model of coronary artery thrombolysis. (2000) (3)
- Protective effects of beta-adrenergic blockade in isolated ischemic hearts. (1980) (3)
- Inability of Potassium Canrenoate to Convert Experimentally Induced Ouabain Arrhythmias in the Canine Heart (1974) (3)
- Prothrombotic effects of thrombolytic therapy in a rat (Rattus norvegicus) model of venous thrombolysis. (2013) (3)
- Hirudin and S18886 Maintain Luminal Patency After Thrombolysis With Alfimeprase (2013) (3)
- HBI-3000 Prevents Secondary Sudden Cardiac Death (2013) (3)
- Electrophysiologic, antiarrhythmic and cardiovascular actions of UM301, a quaternary ammonium compound. (1986) (3)
- The anti-fibrillatory effect of dimethyl quaternary propranolol (UM-272) (1973) (2)
- Postischemic reperfusion is the prerequisite for tunel positivity (2002) (2)
- Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death. (1988) (2)
- Improved coronary blood flow after streptokinase thrombolysis with thromboxane synthetase inhibition in an experimental canine model (1986) (2)
- Leukocytes and Leukocyte-Derived Products in Myocardial Ischemic Injury* (1985) (2)
- The Antiarrhythmic Actions of Intravenous and Oral UM424 in Postinfarction Canine Myocardium (1985) (2)
- Adrenergic-dependent Effect of Adenosine-induced Ventricular Fibrillation in the Isolated Rabbit Heart (1997) (2)
- Cardiac electrophysiologic interactions of bepridil, a new calcium antagonist, with enflurane, halothane, and isoflurane. (1988) (2)
- Cardiac electrophysiologic actions of KB-944 (Fostedil), a new calcium antagonist, in the anesthetized dog. (1984) (2)
- The effects of BL-4162A on the development of coronary artery thrombosis in the conscious dog (1979) (2)
- BMY21190, A Potent Inhibitor of cAMP Phosphodiesterase (1994) (2)
- Preclinical assessment of antiarrhythmic drugs. (1986) (2)
- Reduction of Myocardial Necrosis after Glycosaminoglycan Administration: Effects of a Single Intravenous Administration of Heparin or N-Acetylheparin 2 Hours before Regional Ischemia and Reperfusion (1996) (2)
- Antifibrillatory effects ofclofilium intherabbit isolated heart (1994) (1)
- Antiarrhythmic drugs. Key references. (1979) (1)
- Thrombolytic effects of fibrolase in a canine model of carotid artery thrombosis (1994) (1)
- Effects of dl propranolol (P) and dimethyl propranolol (UM272) on ischemic ST segment changes in the canine heart (1974) (1)
- Protection from ventricular fibrillation by UM-272 in a conscious canine model of sudden coronary death (1982) (1)
- Effect of dimethyl quaternary propranolol (UM 272) on oxygen consumption and ischemic ST segment changes in the canine myocardium (1974) (1)
- Electropharmacology of drugs used in the treatment of ventricular arrhythmias (1978) (1)
- Care , and the animal care use program conforms to the standards in the Guide for the Care and Use of Laboratory Animals (2005) (1)
- ISCHEMIA-INDUCED MYOCARDIAL INJURY (1986) (1)
- The Reduction of Ultimate Infarct Size: State of the Art and Goals for the Future (1987) (1)
- Methylprednisolone and the size of myocardial infarcts. (1978) (1)
- Prevention by propranolol or atenolol of ischemia-induced losses of contractile and subcellular function in isolated blood-perfused hearts (1980) (1)
- Electrophysiologic and antiarrhythmic actions of sulphinpyrazone and its sulfide metabolite G25671. (1987) (1)
- Letter: Potassium canrenoate and digitalis intoxication. (1974) (1)
- Protection of the ischemic myocardium by phentolamine and propranolol (1979) (1)
- COX-1 in Addition to COX-2 Mediates Ischemic Preconditioning (2007) (1)
- Therapeutic advances in the management of cardiac arrhythmias: Part I. Disopyramide (1982) (1)
- The effect of bepridil on irreversible myocardial ischemic injury (1984) (1)
- Antiarrhythmic vs. antifibrillatory activity of the basic diphenylhydantoin derivative 3-[3-(4-phenyl-1-piperidyl)propyl]-5-(4-methoxyphenyl)-5-phenylhydantoin hydrochloride. (1986) (1)
- The synergistic effects of prostacyclin and aminophylline in preventing coronary artery thrombosis (1981) (1)
- The theory and practice of measuring cardiac output by thermodilution techniques (1974) (1)
- Speaking of Pharmacology (2006) (1)
- Antithrombotic and cardiovascular effects of BMY-20844, an inhibitor of cAMP phosphodiesterase, in a canine model of coronary artery thrombosis (1995) (1)
- Protection on globally ischemic cats' hearts by N-dimethylpropranolol (UM-272) (1978) (1)
- Kinetics of antiarrhythmic effects of bretylium: Correlation with myocardial drug concentrations (1980) (1)
- Modulation of hemoprotein hydrogen peroxide mediated peroxidation reactions by sulfhydryl compounds relation to myocardial infarction (1985) (1)
- The Renin – Angiotensin – Aldosterone System and Other Vasoactive Substances 206 (2003) (0)
- Protective effects of lodoxamide tromethamine on global and regional myocardial ischemia (1982) (0)
- Dimethyl propranolol prevents ischemia-induced loss of ventricular compliance and microsomal Ca-accumulation (1979) (0)
- The effect of ibuprofen on the accumulation of 111-Indium labeled platelets in acute canine myocardial infarction (1982) (0)
- Myocardial reperfusion injury—The role of leukocytes and oxygen free radicals (1986) (0)
- Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect. (1984) (0)
- Sildenafil citrate attenuates acute renal injury in an animal model of contrast‐induced nephropathy (LB573) (2014) (0)
- Reduction of ischemic injury by diltiazem (D) in a model of regional ischemia and reperfusion (1981) (0)
- Prostacyclin analog maintains blood flow despite intracoronary thrombus formation in a canine model (1990) (0)
- 2499 – INFLUENCE OF PROSTAGLANDIN SYNTHESIS INHIBITION ON CANINE PERIPHERAL VASCULAR RESPONSES TO VASODILATOR AGENTS (1978) (0)
- A New Topical Drug Delivery System for Nitroglycerin (1981) (0)
- Suppression of reentrant ventricular tachyarrhythmias by bretylium and UM-272 (1980) (0)
- Lack of Concordance Between the Antiarrhythmic and Antifibrillatory Actions of UM‐424, a Quaternary Ammonium Analogue of Propranolol (1987) (0)
- HBI-3000 Prevents Sudden Cardiac Death in a Conscious Canine Model (2010) (0)
- Subject Index, Vol. 23, 1981 (1981) (0)
- Relationship between effective refractory period and ventricular fibrillation threshold after clofilium (1981) (0)
- Antiarrhytmic and electrophysioloic actions of bepridil in chronically infarcted conscious canines (1985) (0)
- Beneficial Effects of Nafazatrom in Experimental Models of Coronary Thrombosis and Myocardial Ischemia (1983) (0)
- Celecoxib administration interferes with the anti‐platelet effect of low dose aspirin in canines (2010) (0)
- Experimental Models for the Assessment of Antiarrhythmic and Proarrhythmic Drug Action: Traditional and Newer Models (1995) (0)
- Pharmacologic basis for the management of supraventricular tachyarrhythmias (1978) (0)
- RO3244794, an IP receptor antagonist, shortens the time to occlusion in a canine model of coronary artery thrombosis (2008) (0)
- Depressed myocardial function and compliance in a model of experimental diabetes in the feline (1986) (0)
- The protective effects of diltiazem in the ischemic isolated blood-perfused cat heart (1981) (0)
- Ventricular fibrillation ina conscious canine preparation ofsudden coronary death prevention byshort- andlong-term amiodarone (1983) (0)
- ATP sensitive potassium channels and ischemic heart disease. (1994) (0)
- Effects of Adenosine on Thrombosis and Thrombolysis in a Canine Experimental Preparation (2001) (0)
- Prevention ofChronic Canine Ventricular Tachyarrhythmias withBretylium Tosylate (1981) (0)
- cAln Official Jiournal ofthecAmericanHeart cyAssociation, Inc. FEATURES Freeradicals andmyocardial injury: pharmacologic (1986) (0)
- Role of the sympathetic nervous system in bretylium's antifibrillatory action (1982) (0)
- Diagnostic exercise. (1982) (0)
- Effects of N-dimethyl propranolol (UM-272) on isolated cardiac mitochondria and microsomes. (1979) (0)
- Medroxyprogesterone Acetate Prevents the Cardioprotective Effects of 17β‐estradiol (2006) (0)
- Sublingual absorption of the quaternary ammonium antiarrhythmic agent, UM-272. (1983) (0)
- High dose intravenous aspirin vs low dose intravenous or oral aspirin in experimental coronary vascular injury (1991) (0)
- 2001 Torald Sollmann Award lecture. Looking toward the future, using lessons from the past. (2001) (0)
- Tissue distribution and antiarrhythmic action of N-dimethyl-propranolol (UM-272) in the dog (1979) (0)
- Thrombin inhibition and endogenous prostacyclin prevent reocclusion in carotid artery thrombosis after alfimeprase‐induced thrombolysis (2011) (0)
- Preconditioning reduces tissue complement gene expression in the rabbit isolated heart. (1999) (0)
- Effects of electrolysis on myocardial performance of isolated Langendorff-perfused rabbit hearts * (1984) (0)
- Reply to the Above Letter (1974) (0)
- Occlusion-reperfusion model of ischemic injury (2002) (0)
- Occlusion-reperfusion model of ischemic injury (2002) (0)
- The Role of Complement in Myocardial Inflammation and Reperfusion Injury (2003) (0)
- 0253: Burst Mode Ultrasound with Contrast Agent Injures Cardiomyocytes in Vivo (2009) (0)
- Thrombostatin inhibits cyclic flow variations in the folts model of canine coronary artery thrombosis (2000) (0)
- Recent advances in cardiovascular pharmacology. (1974) (0)
- Role of the Terminal Complement Components (2005) (0)
- Atorvastatin‐induced cardiac function impairment (2013) (0)
- A thermostable mutant of a bacterial cocaine esterase reverses acute cocaine toxicity in the rabbit isolated heart (2010) (0)
- Contents, Vol. 23, 1981 (1981) (0)
- The protective effect of the dimethyl quaternary derivative of propranolol (UM-272) on myocardial damage due to ischemic arrest (1977) (0)
- Suppression of reentrant ventricular tachycardia in post-infarction canine myocardium by UM-424 (1980) (0)
- Electrophysiologic changes in the ischemic canine heart as effected by pranolium (UM-272) (1978) (0)
- The Early Phase of Preconditioning is Abrogated by COX‐2 Inhibition, but not by a Specific Prostaglandin Receptor Antagonist (2008) (0)
- Suppression of reentrant ventricular tachyarrhythmias by chronic bretylium therapy in postinfarction conscious dogs (1980) (0)
- Expert Answers to Three Key Questions How important is oxidative stress in ischemia , reperfusion , and heart failure ? (2004) (0)
- Extension of myocardial injury by intermittent coronary artery blood flow after thrombolysis: Benefits of adjunctive therapy by inhibiting platelet aggregation (1992) (0)
- Anti-Inflammatory Properties of Monoclonal Anti-Mo1 (CD11b/CD18) Antibodies In Vitro and In Vivo (1990) (0)
- The expanding clinical role of beta-adrenergic receptor blockade (1979) (0)
- Antiarrhythmic and cardiovascular actions of the new antibiotic agent pirlimycin adenylate. (1983) (0)
- Coronary flow responses to platelet activating factor: Release of a platelet-derived coronary artery vasodilator (1985) (0)
- The pharmacologic approach to the treatment of the failing myocardium (1973) (0)
- An evaluation of the antiarrhythmic action of potassium carenoate in the digitalis intoxicated heart (1973) (0)
- Effects of the dimethyl quaternary analog of propranolol (UM-272, SC-27761) on myocardial ischemic injury after coronary artery occlusion: assessed by electrocardiographic and enzymatic changes (1977) (0)
- Myocardial ischemia induced alteration in cardiac sensitivity to digitalis (1977) (0)
- Antiarrhythmic Drugs (2003) (0)
- Are electrocardiogram premature complexes induced by ultrasonic cavitation biomarkers for cardiomyocyte necrosis (2010) (0)
- Therapeutic advances in the management of cardiac arrhythmias: Part II: Bretylium (1982) (0)
- Electrolysis and its effects on the myocardial performance of the isolated Langendorff-perfused rabbit heart (1985) (0)
- Stress Proteins and Myocardial Protection (2020) (0)
- Acute myocardial infarction-complement, neutrophils, and oxygen in reperfusion injury (1992) (0)
- Reduction by Superoxide Dismutase but not Catalase (2005) (0)
- complement components Effects of complement activation in the isolated heart. Role of the terminal (2011) (0)
- New Drugs in Cardiovascular Medicine (1991) (0)
- Inability of methylprednisolone (MP) to reduce infarct size in dogs (1976) (0)
- Complement activation and myocyte damage (1991) (0)
- Reduction of myocardial oxygen consumption and ischemic ST segment changes by dimethyl quaternary propranolol (UM 272; SC 27761) (1975) (0)
- Subject Index, Vol. 30, 1985 (1985) (0)
- The antifibrillatory properties of quaternary ammonium derivatives of propranolol and lidocaine (1973) (0)
- Official Jiournal of the cAmerican Heart cyAssociation , Inc . FEATURES Free radicals and myocardial injury : pharmacologic implications (2005) (0)
- LEUKOCYTES, OXYGEN RADICALS, AND MYOCARDIAL TO ISCHEMIA AND REPERFUSION* INJURY DUE (1988) (0)
- Intravenous prenalterol in acute and chronic heart failure. (2009) (0)
- A novel glutathione preparation protects the ischemic rabbit heart after oral administration (2011) (0)
- butanoyl } amino ) acetyl ] amino } propanoic Acid Dihydrochloride ( CRL 42796 ) , in Combination with Aspirin and / or Enoxaparin , Prevents Coronary Artery Rethrombosis after Successful Thrombolytic Treatment by Recombinant Tissue Plasminogen Activator (2003) (0)
- Monoclonal Antibody That Alters Leukocyte Function (2005) (0)
- Myocardial Reperfusion: Role of Adjunctive Agents to Improve Reperfusion and Prevent Reperfusion Injury (1989) (0)
- Structure of Thrombin Bound to the Inhibitor FM19 (2008) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Benedict Robert Lucchesi?
Benedict Robert Lucchesi is affiliated with the following schools:
